Tag: CBT > Controlled Substances Act: Page 2

Advocacy for Cannabis Legalization

Senate Democrats Introduce Bill to Federally Legalize Cannabis

The Cannabis Administration and Opportunity Act aims to deschedule marijuana by removing it from the Controlled Substances Act.

May 1, 2024

Cannabis Rescheduling

DEA’s 5-Factor Test Makes Rescheduling Cannabis Impossible

After HHS used its own two-part test to determine the plant’s ‘currently accepted medical use,’ rescheduling opponents urge DEA to keep its five-part test.

March 19, 2024

New Mexico

Bright Green Corp. Submits DEA Registration For Production of Schedule I, II Controlled Substances

The application follows the company’s approval from the New Mexico Board of Pharmacy this year.

March 7, 2024

Regulations and Reform

DOJ Declines to Address Media Inquiry on Cannabis Rescheduling, Points to 2020 Resource Guide

A Department of Justice spokesperson said the government has nothing further to provide beyond its confirmation of review.

February 27, 2024

Legislation and Regulation

DEA, Attorney General Miss Deadline to Respond to 12 US Senators on Cannabis Rescheduling

The Drug Enforcement Administration continues to keep its process behind closed doors despite a congressional letter demanding transparency.

February 14, 2024

Legislation and Regulation

12 US Senators Say Cannabis Should Be Descheduled, Demand Transparency From DEA

The dozen Democrats requested responses to six questions regarding the DEA’s rescheduling process.

January 30, 2024

Legislation and Regulation

Biden Reaffirms Cannabis Stance During Campaign Stop

The president said he’s kept his promise on reform during a political event at South Carolina’s First-in-the-Nation dinner.

January 29, 2024

Cannabis Rescheduling

Colorado Attorney General Leads Multistate Effort to Support Cannabis Rescheduling

Attorney General Phil Weiser spearheaded a letter signed by 11 other state attorneys general to encourage the Drug Enforcement Administration to reclassify cannabis as a Schedule III drug under the Controlled Substances Act.

January 16, 2024

Alabama

CBT’s Most Popular Articles: December

Here are Cannabis Business Times’ most-viewed stories this month.

December 28, 2023

Cannabis Rescheduling

Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation

Eric Berlin, partner at Dentons, shares insight into some of the arguments the 29 former attorneys make against removing cannabis from Schedule I of the Controlled Substances Act.

December 21, 2023

Federal Cannabis Legalization

US Congressman Introduces Bill to Remove Cannabis From CSA, Allow Interstate Commerce, Provide 280E Relief

The legislation has bipartisan support, including from the co-chairs of the Congressional Cannabis Caucus.

December 8, 2023

Ohio

The Top 10: CBT's Most-Read Articles in November

Here's a recap and list of the stories readers engaged most with this month.

November 29, 2023